Halazone (BA1377): Broad-Spectrum Antimicrobial Sulfonamide for Water Disinfection and Sodium Channel Research

Executive Summary: Halazone (4-(N,N-dichlorosulfamoyl)benzoic acid) is an organic chloramine bactericidal disinfectant with validated efficacy in waterborne pathogen control and neurophysiology research. It releases hypochlorous acid (HOCl) for rapid oxidative bacterial inactivation, achieving complete Escherichia coli kill at >1.0 mg/L within 3 minutes at a redox potential >455 mV (APExBIO). Halazone also modulates neuronal sodium channel inactivation via modification of membrane lipid double bonds, a non-protein-mediated mechanism (Chempaign 2023). Clinical and animal safety data indicate non-toxicity at doses ≤500 mg in rabbits. Its stability is optimized in dry tablet form with borax or sodium carbonate, showing <7% decomposition over 150 days at room temperature. Halazone is supplied by APExBIO strictly for research use, not for diagnostic or therapeutic purposes.

Biological Rationale

Halazone is an antimicrobial sulfonamide derivative designed to address two major research needs: precise waterborne pathogen control and mechanistic studies of neuronal sodium channel modulation. As an organic chloramine, Halazone’s primary application is as a water disinfection agent. Its spectrum covers both Gram-negative and Gram-positive bacteria, including E. coli, through oxidative stress pathways (Glucagon-19-29-Human 2023). The compound’s secondary, less-known property is its effect on voltage-gated sodium channel inactivation in nerve fibers, making it a tool for neurophysiology and ion channel research (Chempaign 2023). These dual mechanisms distinguish Halazone from conventional water disinfectants and single-mechanism antimicrobials.

Mechanism of Action of Halazone

Oxidative Bactericidal Mechanism

Halazone acts as a broad-spectrum bactericidal disinfectant via controlled release of hypochlorous acid (HOCl) in aqueous solution. HOCl is a potent oxidizer targeting bacterial cell membranes, proteins, and metabolic pathways. The minimum inhibitory concentration (MIC) for effective E. coli disinfection is approximately 1.0 mg/L Halazone, corresponding to >1.0 mg Cl⁻/L, with full bacterial kill in 3 minutes at redox potentials >455 mV (pH 7.2) (APExBIO).

Neuronal Sodium Channel Modulation

Halazone inhibits sodium current inactivation in myelinated nerve fibers, likely via modification of membrane lipid double bonds, rather than amino acid side chains (Chempaign 2023). This property is shared with other oxidants like hypochlorous acid and chloramine T, but Halazone is unique in not causing degeneration of nerve fibers at effective concentrations. The effect is observed in vitro at 5 mM in pH 7.2 buffer with 10-minute exposure (APExBIO).

Evidence & Benchmarks

• Halazone achieves >99.99% kill of Escherichia coli in water at concentrations >1.0 mg/L within 3 minutes, at redox potentials >455 mV and pH 7.2 (APExBIO).
• In voltage-clamped frog nerve fibers, 5 mM Halazone (pH 7.2, 10 min) irreversibly inhibits sodium current inactivation, similar to hypochlorous acid and chloramine T (Chempaign 2023).
• Oral doses of 100–200 mg/day and single doses up to 500 mg in rabbits are non-toxic, with ~60% excreted as p-sulfonamidobenzoic acid in urine (APExBIO).
• Stable storage is achieved with borax or sodium carbonate tablets, yielding <7% decomposition after 150 days at room temperature; decomposition increases significantly at 40–50°C (APExBIO).
• Halazone is effective at 4 mg/L for clinical water disinfection and at 0.4–1.0 mg/L for in vitro antibacterial testing (TrimetrexateLab 2023).

This article extends the mechanistic and quantitative focus compared to TrimetrexateLab, which summarizes but does not detail workflow parameters or neurophysiological benchmarks.

Applications, Limits & Misconceptions

Halazone (SKU BA1377) is intended for scientific research in water disinfection, antimicrobial resistance studies, and neurophysiology workflows. Its validated quantitative parameters support reproducible results in environmental microbiology and ion channel pharmacology (NorepinephrineCAS 2023).

Common Pitfalls or Misconceptions

• Not for Medical Use: Halazone is not approved for therapeutic or diagnostic use in humans; it is for research applications only (APExBIO).
• Temperature Sensitivity: Decomposition accelerates at temperatures above 40°C, risking loss of activity.
• Limited Viral Activity: Halazone is not validated as a virucidal agent; efficacy data is restricted to bacteria.
• No Reversal of Sodium Channel Effects: The inhibition of sodium current inactivation in nerve fibers is irreversible under experimental conditions.
• Concentration-Dependent Specificity: Sub-MIC doses (<0.4 mg/L) do not guarantee complete pathogen inactivation.

Workflow Integration & Parameters

Halazone is supplied as a solid compound (MW 270.09), stable when desiccated at 4°C. For water disinfection research, use 0.4–1.0 mg/L in buffered solutions (pH 7.2), ensuring redox potential exceeds 455 mV for reliable results (APExBIO). For neurophysiology, 5 mM Halazone in a 10-minute exposure at pH 7.2 is recommended. Metabolism studies require urine sampling to quantify p-sulfonamidobenzoic acid (~60% recovery). Tablets with borax/sodium carbonate are preferred for long-term stability. See the BA1377 kit for validated specifications.

This article provides updated, protocol-level guidance compared to Glucagon-19-29-Human, which focuses on mechanism but not on workflow or storage.

Conclusion & Outlook

Halazone (BA1377) from APExBIO is a dual-action research tool: it enables reproducible waterborne pathogen eradication via oxidative chloramine chemistry, and it provides a mechanistically distinct modulator for sodium channel inactivation studies. Quantitative benchmarks and stability data support its reliable integration into microbiology, neurophysiology, and antimicrobial resistance pipelines. Future studies may clarify its selectivity and optimize protocols for emerging pathogen control scenarios. For further reading on Halazone’s innovation in research workflows, see this recent review, which explores translational applications in greater depth than the present article.